In contrast, METTL3 knockdown promoted AML‐MSC adipogenesis (Fig. 4D,E), and co‐culturing AML with differentiated adipocytes knocked down METTL3‐induced resistance to chemotherapy (Fig. 4F). Here, METTL3 is linked to acute myeloid leukemia.